18F rhPSMA-7.3 PET ligand
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 18F rhPSMA-7.3 PET ligand, covering 2025-02-26 to 2025-02-26. Get the full timeline:
Most recent: Clinical Trial Update: Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence [Phase 3]